当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Incidence Risk Variables for Lung Cancer Patients with Bone Metastases

Lee Wang

Utilizing the Surveillance, Epidemiology, and End Results (SEER) database to examine the homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis (BM). Between 2010 and 2015, the SEER database analyzed the medical records of lung cancer patients with or without bone metastasis. A multivariate Cox regression was used to determine the prognostic effects of each variable on survival, and a multivariate logistic regression was used to identify risk factors. The SEER database contained 34,585 eligible patients who were included in the analysis. Male gender and liver metastasis were positively associated with a risk of bone metastasis in lung cancer patients, as was the prognosis of the disease. Adenocarcinoma, metastasis to the brain, a younger age, a lower grade of tumor differentiation, a higher N stage (N3), and a risk of BM were all positively correlated with an unfavorable prognosis. For the prognosis of bone metastasis, age, race, marital status, tumor size, and pathologic type were independent risk factors. A rate of 25.9% of lung cancer patients experience bone metastasis-related morbidity. This study's estimates of the homogeneous and heterogeneous risk factors for lung cancer patients' incidence and prognosis of bone metastasis may serve as clinical guidelines for doctors.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。